Briefing: Beyond lipid nanoparticles: How custom polymers and AI may reshape gene therapies

Nucleic acids, including DNA and RNA, are fundamental components in gene therapies, necessitating efficient delivery into cells for therapeutic efficacy.

Chemical carrier systems are critical for facilitating the entry of these nucleic acids into target cells, ensuring that they can perform their intended functions.

The integration of custom polymers and AI technologies is emerging as a significant advancement in the design of these delivery systems, potentially reshaping the landscape of gene therapies.